Guía de Práctica Clínica sobre Cuidados Paliativos - GuíaSalud

99. Viola RA, Wells GA, Peterson J. The effects of fluid status and fluid therapy
on the dying: a systematic review. J Palliat Care. 1997;13(4):41-52.
100. Turner T, Cassano AM. Subcutaneous dextrose for rehydration of elderly
patients--an evidence-based review. BMC Geriatr. 2004;4:2.
101. Rochon PA, Gill SS, Litner J, Fischbach M, Goodison AJ, Gordon M. A systematic
review of the evidence for hypodermoclysis to treat dehydration in
older people. J Gerontol A Biol Sci Med Sci. 1997;52(3):M169-M176.
102. Chan K, Sham M, Tse D, Thorsen A. Palliative medicine in malignant respiratory
disease. En: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook
of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
103. Congleton J, Muers MF. The incidence of airflow obstruction in bronchial
carcinoma, its relation to breathlessness, and response to bronchodilator therapy.
Respiratory Medicine. 1995;89(4):291-6.
104. Dorman S, Byrne A, Edwards A. Which measurement scales should we use to
measure breathlessness in palliative care? A systematic review. Palliat Med.
2007;21(3):177-91.
105. Gallagher R. An approach to dyspnea in advanced disease. Can Fam Physician.
2003;49:1611-6.
106. Gallagher R, Roberts D. A systematic review of oxygen and airflow effect on
relief of dyspnea at rest in patients with advanced disease of any cause. Journal
of Pain �� Palliative Care Pharmacotherapy. 2004;18(4):3-15.
107. Booth S, Wade R, Johnson M, Kite S, Swannick M, Anderson H. The use of
oxygen in the palliation of breathlessness. A report of the expert working group
of the Scientific Committee of the Association of Palliative Medicine. Respir
Med. 2004;98(1):66-77.
108. Jennings A-L, Davies AN, Higgins JPT, Gibbs JSR, Broadley KE. A systematic
review of the use of opioids in the management of dyspnoea. Thorax.
2002;57(11):939-44.
109. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised,
double blind, placebo controlled crossover trial of sustained release morphine
for the management of refractory dyspnoea. BMJ. 2003;327(7414):523-8.
110. Viola R, Kiteley C, Lloyd N, Mackay JA, Wilson R, and the Supportive Care
Guidelines Group. The Management of Dyspnea in Cancer Patients: A Clinical
Practice Guideline. A Quality Initiative of the Program in Evidence-based Care
(PEBC). Disponible en: www cancercare on ca/ [accedido en: septiembre 2007]
111. Navigante AH, Cerchietti LCA, Castro MA, Lutteral MA, Cabalar ME. Midazolam
as Adjunct Therapy to Morphine in the Alleviation of Severe Dyspnea
Perception in Patients with Advanced Cancer. Journal of Pain and Symptom
Management. 2006;31(1):38-47.
184 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS